Episode 10 of this series of the Mantell Associates Network welcomes Peter Halling, CEO of Fertin Pharma, an 800 strong CDMO operating across Denmark, India and Canada.
In this episode Alessandro Mantell speaks with Peter Halling, who is an executive professional within the Life Sciences field. He has over 21 years of experience in companies like Novozymes, Ingredion and DohlerGroup, and is currently the CEO of Fertin Pharma A/S. Peter does not come from a strictly traditional background – as a Commercial professional he has been involved in Direct Sales and Account Management for past businesses, and is now in charge of taking Fertin Pharma to the next level.
Fertin Pharma helps leading global brands create pharmaceutical and nutraceutical products to support healthier living. They develop and manufacture innovative oral and intra-oral delivery systems that enhance the efficacy of your active and functional ingredients – without compromising on taste-masking, texture and the consumer experience.
With more than 800 employees across our R&D centres and manufacturing facilities in Canada, Denmark and India, we produce approximately 3 billion units a year, used by consumers all over the world.
The aim of the Mantell Associates Network Podcastis to connect people all around the world and empower people and businesses by sharing the stories, advice and outlook of influential leaders at market-leading companies across the industry. This podcasts provides exposure for the individuals and businesses currently doing great things, and works to unify the Pharmaceutical & Life Science industry.
Mantell Associates is a specialist Pharmaceutical and Life Sciences Recruitment organisation. To find out how we can help with your headhunting or recruitment needs, or if joining us on the podcast and sharing your experience with the rest of the Pharmaceutical & Life Science industry is something you’d be interested in doing, contact us on +44 (0)20 3854 7700.